77 related articles for article (PubMed ID: 4014106)
21. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
Burkert K; Beckmann H
Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
[TBL] [Abstract][Full Text] [Related]
22. Measurement of gallbladder emptying sequentially using a single dose of 99mTc-labeled hepatobiliary agent.
Krishnamurthy GT; Bobba VR; Kingston E; Turner F
Gastroenterology; 1982 Oct; 83(4):773-6. PubMed ID: 6286401
[TBL] [Abstract][Full Text] [Related]
23. The daily rhythm of cortisolemia in hepatic cirrhosis.
Ruzyllo E; Dzieniszewski J; Milewski B; Krygier T
Mater Med Pol; 1973; 5(1):9-16. PubMed ID: 4774849
[No Abstract] [Full Text] [Related]
24. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
[TBL] [Abstract][Full Text] [Related]
25. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
[TBL] [Abstract][Full Text] [Related]
26. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure.
Pimstone B; Epstein S; Hamilton SM; LeRoith D; Hendricks S
J Clin Endocrinol Metab; 1977 Feb; 44(2):356-60. PubMed ID: 320223
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and organ catabolism of cholecystokinin octapeptide in pigs.
Cuber JC; Bernard C; Gibard T; Chayvialle JA
Regul Pept; 1989 Dec; 26(3):203-13. PubMed ID: 2623187
[TBL] [Abstract][Full Text] [Related]
28. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.
Sheppard M; Shapiro B; Pimstone B; Kronheim S; Berelowitz M; Gregory M
J Clin Endocrinol Metab; 1979 Jan; 48(1):50-3. PubMed ID: 422706
[TBL] [Abstract][Full Text] [Related]
29. Human pancreatic polypeptide in chronic renal failure and cirrhosis of the liver: role of kidneys and liver in pancreatic polypeptide metabolism.
Boden G; Master RW; Owen OE; Rudnick MR
J Clin Endocrinol Metab; 1980 Sep; 51(3):573-8. PubMed ID: 7410534
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels of proinsulin, insulin and C-peptide in chronic renal, hepatic and muscular disorders.
Imamura Y; Yokono K; Shii K; Hari J; Sakai H; Baba S
Jpn J Med; 1984 Feb; 23(1):3-8. PubMed ID: 6379242
[TBL] [Abstract][Full Text] [Related]
31. Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro.
Koulischer D; Moroder L; Deschodt-Lanckman M
Regul Pept; 1982 Aug; 4(3):127-39. PubMed ID: 6291099
[TBL] [Abstract][Full Text] [Related]
32. [Lower amines in the blood and urine in chronic liver and kidney diseases].
Martin R; Pohl A; Rotzsch W
Dtsch Z Verdau Stoffwechselkr; 1977; 37(2):85-8. PubMed ID: 608434
[No Abstract] [Full Text] [Related]
33. Elimination of 16-acetyl-gitoxin in patients suffering from impaired liver function.
Haustein KO; Sensing H; Wesser M
Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):379-81. PubMed ID: 3623742
[TBL] [Abstract][Full Text] [Related]
34. [Cholecystokinin-pancreozymin (CCK-PZ)].
Sakaguchi H; Iwata Y; Kobayashi K; Arakawa T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():505-7. PubMed ID: 16149563
[No Abstract] [Full Text] [Related]
35. Effect of doxycycline administration on nitrogen excretion in bilharzial hepatic fibrosis and chronic renal failure cases.
Hafiez AA; El-Kirdassy ZH; Abdel Khalik F; Hassaballa A; El-Ghonaimy E; Gaber A
J Egypt Med Assoc; 1976; 59(3-4):273-86. PubMed ID: 1032145
[No Abstract] [Full Text] [Related]
36. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.
Lydiard RB; Ballenger JC; Laraia MT; Fossey MD; Beinfeld MC
Am J Psychiatry; 1992 May; 149(5):691-3. PubMed ID: 1575262
[TBL] [Abstract][Full Text] [Related]
37. Plasma beta endorphin in cirrhosis and renal failure.
Thornton JR; Losowsky MS
Gut; 1991 Mar; 32(3):306-8. PubMed ID: 2013426
[TBL] [Abstract][Full Text] [Related]
38. Plasma pancreatic trypsinogens in chronic renal failure and after nephrectomy.
Geokas MC; Reidelberger R; O'Rourke M; Passaro E; Largman C
Am J Physiol; 1982 Feb; 242(2):G177-82. PubMed ID: 7065144
[TBL] [Abstract][Full Text] [Related]
39. Effect of cirrhosis and renal failure on the kinetics of clotiazepam.
Ochs HR; Greenblatt DJ; Knüchel M
Eur J Clin Pharmacol; 1986; 30(1):89-92. PubMed ID: 2872061
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal function.
Kirch W; Nokhodian A; Halabi A; Weidinger G
Eur J Drug Metab Pharmacokinet; 1992; 17(1):33-8. PubMed ID: 1499595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
